Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v1-EN
Language French English
Date Updated 2020-09-22 2020-08-18
Drug Identification Number 02319500 02319500
Brand name TEVA-SILDENAFIL R TEVA-SILDENAFIL R
Common or Proper name TEVA-SILDENAFIL R 20MG COATED TABS TEVA-SILDENAFIL R 20MG COATED TABS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients SILDENAFIL SILDENAFIL
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C02KX C02KX
ATC description OTHER ANTIHYPERTENSIVES OTHER ANTIHYPERTENSIVES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-08-18 2020-08-18
Estimated end date 2021-01-31 Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Will be allocating to 100% of Teva Market.
Health Canada comments